The American Journal of Managed Care3d
Contributor: The Critical Role of Patient Engagement in Patient-Centered Outcomes Research and Health Technology Assessment of Rare Disease Treatments
Patient engagement is a necessity when performing health technology assessment to help better assess and identify the outcomes of a rare disease.
Inhalable Drugs Market Set For Rapid Growth And Trend By 2024-2031 Key Drivers And Analysis Omron Healthcare, Inc
Global Inhalable Drugs market size is expected to reach US$ 56.68 Bn by 2030, from US$ 34.86 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period. Mr. Shah Coherent Market Insights Pvt.